March 20, 2015
At the auction for a communal block of shares (29.95%) of the SIC Borshchahivskii Chemical Pharmaceutical Plant PJSC (Kyiv) the company Kub, representing the company Darnitsa, bought the block for UAH 171.844 mln. The reserved price was UAH 143.2 mln. Press office of Kyiv Council informed about this today, on March, 20.
The purchased block does not allow Darnitsa to influence operational activities of BCCP.
As of March, 19, there were five registered participants of the auction. Namely: the investment company Dragon Capital, Investment Company Favorit LLC, representing Lumier Farma LLC, DNK Capital LLC and FK Kub LLC. Aside from Darnitsa, the company Panteon K was admitted to take part in the auction. Other bidders were not admitted to the auction due to absence of margins.
SIC Borshchahivskii Chemical Pharmaceutical Plant PJSC was created on January 15, 1997. BCPP produces around 100 items of medicines and takes up 10% of the Ukrainian pharmaceutical market. In 2013 the net profit of BCPP increased by 21.5% percent compared to the previous period - to 74.983 mln hryvnias, and the net revenue increased by 13.8%, to 638.94 mln hryvnias. Another shareholders of BCPP are Lenik Group S.A. - 20.3168% and Beldor Group - 21.2637%, both registered on the British Virgin Islands.
The pharmaceutical company Darnitsa produces around 250 items of medical products on the production facilities of more than 30 thousand sq.m. The production facilities of Darnitsa enable production of more than 400 mln ampoule, 4 bln pills, 30 mln bottles of sterile antibiotics and more than 30 mln tubes of soft medical forms. The annual production of the drops production section is 35 bottles. The pharmaceutical company Darnitsa obtained a net profit of UAH 200.2 mln in 2013.